Prostate specific antigen testing among the elderly--when to stop? (Q34604893)

3 August 2017

title

Prostate specific antigen testing among the elderly--when to stop? (English)

1 reference

3 August 2017

1

Edward M Schaeffer

1 reference

3 August 2017

2

H Ballentine Carter

1 reference

3 August 2017

6

Patricia Landis

1 reference

3 August 2017

Anna Kettermann

3

1 reference

3 August 2017

Stacy Loeb

4

1 reference

3 August 2017

Luigi Ferrucci

5

1 reference

3 August 2017

Bruce J Trock

7

1 reference

3 August 2017

E Jeffrey Metter

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 February 2009

1 reference

3 August 2017

1 reference

3 August 2017

volume

181

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

1606-14; discussion 1613-4

1 reference

Surgical management of high risk prostate cancer: the Mayo Clinic experience

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Prostate-specific antigen levels as a predictor of lethal prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

The changing face of prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

20-year outcomes following conservative management of clinically localized prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

A piece of my mind. Winners and losers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

American Cancer Society guidelines for the early detection of cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

PSA screening among elderly men with limited life expectancies.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668165

Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA)

26 October 2018

1 reference

12 December 2020

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

12 December 2020

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

12 December 2020

10.1016/J.JURO.2008.11.117

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference